April 20, 2014 6:28 PM ET

Pharmaceuticals

Company Overview of Intrac Inc., prior to reverse merger by Innovative Drug Delivery Systems Inc.

Company Overview

Intrac, Inc. was acquired by Innovative Drug Delivery Systems on 12/06/2004 in a reverse merger transaction. Intrac, Inc. does not have significant operations. It plans to seek, investigate, acquire one or more properties or businesses, as well as to pursue other related activities intended to enhance shareholder value.

180 Varick 13th Floor

New York, NY 10014

United States

Phone:

310-396-1691

Key Executives for Intrac Inc., prior to reverse merger by Innovative Drug Delivery Systems Inc.

Intrac Inc., prior to reverse merger by Innovative Drug Delivery Systems Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
MithraGen, Inc. United States
Innocoll, Inc. United States
Astarix Institute United States
T-19 Inc United States
Edge Therapeutics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Intrac Inc., prior to reverse merger by Innovative Drug Delivery Systems Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.